SEC Form 4 reporting owner

Lucas Svetlana

Lucas Svetlana has filed 5 Form 4 transactions reported between March 13, 2026 and July 31, 2026, as Director of Jasper Therapeutics, Inc., Chief Business Officer of Scribe Therapeutics, Inc. and a reporting owner of aTYR PHARMA INC.

Name as filed: Lucas Svetlana

Open-market buys, 24 mo

$45K

1 lines

Open-market sales, 24 mo

None

reported

Companies

with Form 4 filings

Latest transaction

Jul 31, 2026

transaction date

Roles and reported holdings

JSPRJasper Therapeutics, Inc.
Jul 31, 2026
Director
No common-stock holding reported on a purchase, sale, gift or withholding line.
SCTXScribe Therapeutics, Inc.
Mar 13, 2026 – Jul 23, 2026
Chief Business Officer
Held indirectly (latest line)3,000 sh as of Jul 23, 2026 · Form 4
24 months: $45K bought
ATYRaTYR PHARMA INC
May 11, 2026
Reporting owner
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 5 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Jul 31, 2026	JSPRDirector	Grant or awardCode A · direct	7,500	—	—	7,500	Form 4
Jul 23, 2026	SCTXChief Business Officer	Grant or awardCode A · direct	109,426	—	—	109,426	Form 4
Jul 23, 2026	SCTXChief Business Officer	Open-market purchaseCode P · indirect	3,000	$15.00	$45K@ $15.00	3,000	Form 4
May 11, 2026	ATYR	Grant or awardCode A · direct	50,000	—	—	50,000	Form 4
Mar 13, 2026	SCTXChief Business Officer	Grant or awardCode A · direct	9,547	—	—	9,547	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.